ZNTL - Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference | Benzinga
NEW YORK and SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that Zentalis management is scheduled to participate in a fireside chat at the upcoming Jefferies Global Healthcare Conference on June 5, 2024, at 4:00 p.m. ET.
Access to a live webcast of this event, as well as an archived recording, will be available under the "Events & Presentations" tab on the Investors & Media section of the Company's website.
About Zentalis ...